Abnormal accumulation of human transmembrane (TMEM)-176A and 176B proteins is associated with cancer pathology

Acta Histochemica

Volumn 114, Issue 7, 2012, Pages 705-712

  Cuajungco, Math P ^a,b   Podevin, William ^a   Valluri, Vinod K ^a   Bui, Quang ^a   Nguyen, Van H ^a   Taylor, Katrina ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Breast cancer; Hepatocellular carcinoma; Lymphoma; Melanoma

Indexed keywords

MEMBRANE PROTEIN; TRANSMEMBRANE 176A PROTEIN; TRANSMEMBRANE 176B PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER TISSUE; COLON CANCER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOMETRIUM CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; KIDNEY CANCER; LIVER CANCER; LUNG CARCINOMA; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MASS SPECTROMETRY; OVARY CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SKIN CANCER; STOMACH CANCER; WESTERN BLOTTING;

AMINO ACID SEQUENCE; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION; HEK293 CELLS; HUMANS; LYMPHOMA; MALE; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; SEQUENCE HOMOLOGY, AMINO ACID; TISSUE ARRAY ANALYSIS;

EID: 84863461394     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2011.12.006     Document Type: Article

References (18)

1. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009, 55:611-622.
2. Condamine T., Le Texier L., Howie D., Lavault A., Hill M., Halary F., et al. Tmem176B and Tmem176A are associated with the immature state of dendritic cells. J Leukoc Biol 2010, 88:507-515.
3. Cuajungco M.P., Grimm C., Oshima K., D'Hoedt D., Nilius B., Mensenkamp A.R., et al. PACSINs bind to the TRPV4 cation channel. PACSIN 3 modulates the subcellular localization of TRPV4. J Biol Chem 2006, 281:18753-18762.
4. Cuajungco M.P., Leyne M., Mull J., Gill S.P., Lu W., Zagzag D., et al. Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia. Am J Hum Genet 2003, 72:749-758.
5. Gehrau R., Maluf D., Archer K., Stravitz R., Suh J., Le N., et al. Molecular pathways differentiate hepatitis C virus (HCV) recurrence from acute cellular rejection in HCV liver recipients. Mol Med 2011, 17:824-833.
6. Ghosh H.S., Cisse B., Bunin A., Lewis K.L., Reizis B. Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells. Immunity 2010, 33:905-916.
7. Gottschling S., Jauch A., Kuner R., Herpel E., Mueller-Decker K., Schnabel P.A., et al. Establishment and comparative characterization of novel squamous cell non-small cell lung cancer cell lines and their corresponding tumor tissue. Lung Cancer 2012, 75:45-57.
8. Hodo Y., Hashimoto S., Honda M., Yamashita T., Suzuki Y., Sugano S., et al. Comprehensive gene expression analysis of 5'-end of mRNA identified novel intronic transcripts associated with hepatocellular carcinoma. Genomics 2010, 95:217-223.
9. Louvet C., Chiffoleau E., Heslan M., Tesson L., Heslan J.M., Brion R., et al. Identification of a new member of the CD20/FcepsilonRIbeta family overexpressed in tolerated allografts. Am J Transplant 2005, 5:2143-2153.
10. Lurton J., Rose T.M., Raghu G., Narayanan A.S. Isolation of a gene product expressed by a subpopulation of human lung fibroblasts by differential display. Am J Respir Cell Mol Biol 1999, 20:327-331.
11. Maeda Y., Fujimura L., O-Wang J., Hatano M., Sakamoto A., Arima M., et al. Role of Clast1 in development of cerebellar granule cells. Brain Res 2006, 1104:18-26.
12. Motz G.T., Coukos G. The parallel lives of angiogenesis and immunosuppression: cancer and other tales. Nat Rev Immunol 2011, 11:702-711.
13. Nakajima H., Takenaka M., Kaimori J.Y., Nagasawa Y., Kosugi A., Kawamoto S., et al. Gene expression profile of renal proximal tubules regulated by proteinuria. Kidney Int 2002, 61:1577-1587.
14. Ryu S.H., Kim K.H., Kim H.B., Kim M.H., Kim N.H., Kang Y., et al. Oncogenic Ras-mediated downregulation of Clast1/LR8 is involved in Ras-mediated neoplastic transformation and tumorigenesis in NIH3T3 cells. Cancer Sci 2010, 101:1990-1996.
15. Strelnikov V., Tanas A., Shkarupo V., Kuznetsova E., Gorban N., Zaletaev D. Non-microarray DNA differential methylation screening in breast cancer. Cancer Genet Cytogenet 2010, 203:93.
16. Wang Y., Han K.J., Pang X.W., Vaughan H.A., Qu W., Dong X.Y., et al. Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J Immunol 2002, 169:1102-1109.
17. Zamarron B.F., Chen W.F. Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci 2011, 7:651-658.
18. Zuccolo J., Bau J., Childs S.J., Goss G.G., Sensen C.W., Deans J.P. Phylogenetic analysis of the MS4A and TMEM176 gene families. PLoS One 2010, 5:e9369.